Carbonic Anhydrase Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Carbonic Anhydrase Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hibrow Hlthcare | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 211556-002 | Oct 18, 2019 | BX | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novitium Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 210588-001 | Oct 17, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ne Rx Pharma | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 217197-002 | May 9, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 040195-001 | May 28, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 040195-002 | May 28, 1997 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rubicon | ACETAZOLAMIDE | acetazolamide | TABLET;ORAL | 215101-001 | Aug 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
